MHRA: Warning to be added to paclitaxel device IFUs in Europe - Vascular News

MHRA: Warning to be added to paclitaxel device IFUs in Europe  Vascular News

Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management